Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01816477 · ClinicalTrials.gov registry record · NA
Post Operative Pain Control Using Ropivacaine and the ON-Q System in the Adult Pectus Excavatum Patient
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT01816477: Completed NA study, sponsored by Mayo Clinic.
NCT01816477 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01816477, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
Pectus excavatum (PE) is a common chest wall deformity where the sternum is displaced posteriorly. In severe cases, surgery is performed to correct the defect. In recent years, minimally invasive surgery with the placement of stainless steel support bars has been increasingly performed in patients over the age of 17 years. Because of the decreased malleability and tremendous pressure required to hold the chest wall in the corrected position, post-operative pain control has been a significant problem in this patient population. Thoracic epidurals are commonly employed however mean hospitalizations of up to 7 days have been required before adequate pain control on oral analgesics is obtained and patients are suitable for discharge. It is hypothesized that using the ON-Q system (I-Flow Corporation, Lake Forest CA) with bilateral intercostal catheter infusion would provide adequate post operative pain control with a significantly shorter hospital length-of-stay than thoracic epidural. Total use of narcotics for 1 week following surgery would also be less with the ON-Q system versus epidural.
Interventions
- DEVICE ON-Q soaker catheter system
- DRUG Epidural (ropivicaine 0.25%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01816477
The ClinicalTrials.gov registry entry for NCT01816477 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ON-Q soaker catheter system is the first listed.
NCT01816477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01816477 about?
NCT01816477 is a clinical study titled "Post Operative Pain Control Using Ropivacaine and the ON-Q System in the Adult Pectus Excavatum Patient". Pectus excavatum (PE) is a common chest wall deformity where the sternum is displaced posteriorly. In severe cases, surgery is performed to correct the defect. In recent years, minimally invasive surgery with the placement of stainless steel support bars has been increasingly performed in patients o...
What is the current status of trial NCT01816477?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2013-04. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01816477?
The interventions under investigation include: ON-Q soaker catheter system (DEVICE), Epidural (ropivicaine 0.25%) (DRUG).
Who is sponsoring clinical trial NCT01816477?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.